Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
SSgA SPDR ETFs Europe II Public Limited Company - SPDR S&P U.S. Health Care Select Sector UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$42.26 |
52 Week High | US$44.71 |
52 Week Low | US$36.89 |
Beta | 0 |
1 Month Change | -5.42% |
3 Month Change | 0.40% |
1 Year Change | 6.56% |
3 Year Change | 18.59% |
5 Year Change | 68.58% |
Change since IPO | 127.42% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
SXLV | CH Capital Markets | CH Market | |
---|---|---|---|
7D | 0.3% | -0.2% | 0.1% |
1Y | 6.6% | 27.0% | -3.2% |
Return vs Industry: SXLV underperformed the Swiss Capital Markets industry which returned 27% over the past year.
Return vs Market: SXLV exceeded the Swiss Market which returned -3.2% over the past year.
Price Volatility
SXLV volatility | |
---|---|
SXLV Average Weekly Movement | 1.5% |
Capital Markets Industry Average Movement | 3.3% |
Market Average Movement | 3.5% |
10% most volatile stocks in CH Market | 7.2% |
10% least volatile stocks in CH Market | 2.0% |
Stable Share Price: SXLV has not had significant price volatility in the past 3 months.
Volatility Over Time: SXLV's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | n/a | n/a | ie.spdrs.com/en/professional/etf/spdr-sp-us-health-care-select-sector-ucits-etf-ZPDH-GY |
SSgA SPDR ETFs Europe II Public Limited Company - SPDR S&P U.S. Health Care Select Sector UCITS ETF is an exchange traded fund launched and managed by State Street Global Advisors Limited. It is co-managed by State Street Global Advisors, Inc. The fund invests in the public equity markets of the United States.
SSgA SPDR ETFs Europe II Public Limited Company - SPDR S&P U.S. Health Care Select Sector UCITS ETF Fundamentals Summary
SXLV fundamental statistics | |
---|---|
Market cap | US$377.98m |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs SXLV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SXLV income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did SXLV perform over the long term?
See historical performance and comparison